The cancer-promoting potential of fumonisin B1 in rat liver using diethylnitrosamine as a cancer initiator

Cancer Letters

Volumn 109, Issue 1-2, 1996, Pages 101-108

  Gelderblom, W C A ^a,c   Snyman, S D ^a   Lebepe Mazur, S ^a   Van Der Westhuizen, L ^a   Kriek, N P J ^b   Marasas, W F O ^a  

^a Programme on Mycotoxins and Experimental Carcinogenesis   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer promotion; Diethylnitrosamine; Fumonisin B1; Rat liver

Indexed keywords

DIETHYLNITROSAMINE; EPIDERMAL GROWTH FACTOR; FUMONISIN B1; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; PHENOBARBITAL; TRITIUM; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

ANIMALS; CARBOXYLIC ACIDS; CARCINOGENS, ENVIRONMENTAL; DIETHYLNITROSAMINE; DRUG SYNERGISM; FUMONISINS; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MALE; MYCOTOXINS; RATS; RATS, INBRED F344;

EID: 0030568055     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04431-X     Document Type: Article

References (32)

1. 1, in rats, Carcinogenesis, 12, 1247-1251.
2. [2] Sydenham, E.W., Shephard, G.S., Thiel, P.G., Marasas, W.F.O. and Stockenström, S. (1991) Fumonisin contamination of commercial corn-based human foodstuffs, J. Agric. Food Chem., 39, 2014-2018.
3. [3] Farber, E. (1991) Clonal adaptation as an important phase of hepatocarcinogenesis, Cancer Biochem. Biophys., 12, 157-165.
4. [4] Farber, E,. Chen, Z.-Y., Harris, L., Lee, G., Rinaudo, J.S., Roomi, W.M., Rotstein, J. and Semple, E. (1989) The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In: Liver Cell Carcinoma, pp. 273-291. Editors: P. Bannasch, D. Keppler and G. Weber. Kluwer Academic, Dordrecht.
5. [5] Gelderblom, W.C.A., Semple, E. and Farber, E. (1992) The cancer initiating potential of the fumonisin mycotoxins produced by Fusarium moniliforme, Carcinogenesis, 13, 433-437.
6. 1 dosimetry in relation to cancer initiation in rat liver, Carcinogenesis, 15, 209-214.
7. [7] Farber, E. (1995) Cell proliferation as a major risk factor for cancer: a concept of doubtful validity, Cancer Res., 55, 3759-3762.
8. [8] Culumbano, A., Rajalakshmi, S. and Sarma, D.S.R. (1981) Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures, Cancer Res., 41, 2079-2083.
9. 1 on the EGF-induced mitogenic response in primary rat hepatocytes, Carcinogenesis, 16, 625-631.
10. [10] Cawood, M.E., Gelderblom, W.C.A., Vleggaar, R., Berhend, Y., Thiel, P.G. and Marasas, W.F.O. (1991) Isolation of the fumonisin mycotoxins: a quantitative approach, J. Agric. Food Chem., 39, 1958-1962.
11. [11] Ogawa, K., Solt, D. and Farber, E. (1980) Phenotypic diversity as an early property of putative preneoplastic cells in liver carcinogenesis, Cancer Res., 40, 725-733.
12. [12] Tatematsu, M., Aoki, T., Kagawa, M., Mera, Y. and Ito, N. (1988) Reciprocal relationship between development of glutathione S-transferase positive foci and proliferation of surrounding hepatocytes in rats, Carcinogenesis, 9, 221-225.
13. 1, Cancer Res., 40, 4739-4743.
14. [14] Giles, K.W. and Myers, A. (1965) An improved diphenylamine method for the estimation of deoxyribonucleic acid, Nature, 206, 93.
15. [15] Smuts, C.M., Kruger, M., Van Jaarsveld, P.J., Fincham, J.E., Schall, R., Van der Merwe, K.J. and Benadé, A.J.S. (1992) The influence of fish oil supplementation on plasma lipoproteins and arterial lipids in vervet monkeys with established atherosclerosis, Prost. Leukot. Essential Fatty Acids, 47, 129-138.
16. [16] Riley, R.T., Wang, E. and Merrill Jr, A.H. (1994) Liquid chromatography of sphinganine and sphingosine: use of the sphinganine to sphingosine ratio as a biomarker for consumption of fumonisins, J. AOAC Int., 77, 533-540.
17. [17] Hayes, M.A., Roberts, E., Roomi, M.W., Safe, S.H., Faber, E. and Cameron, R.G. (1984) Comparative influences of different PB-type and 3-MC-type polychlorinated biphenyl-induced phenotypes on cytocidal hepatotoxicity of bromobenzene and acetaminophen, Toxicol. Appl. Pharmacol., 76, 118-127.
18. [18] Schulte-Herman, R., Ohde, G., Schuppler, H.G. and Timmermann-Trosiener, I. (1981) Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds and nafenopin, Cancer Res., 41, 2556-2562.
19. 1 in human keratinocytes, fibroblast, esophageal epithelial cells and hepatoma, Carcinogenesis, 17, 239-249.
20. [20] Abbas, H.K., Gelderblom, W.C.A., Cawood, M.E. and Shier, T.W. (1993) Biological activities of fumonisin mycotoxins from Fusarium moniliforme in jimsonweed (Datura stramonium L.) and mammalian cell cultures, Toxicon, 31, 345-353.
21. [21] Yoo, H.-S., Norred, W.P., Wang, E., Merrill, A.H. and Riley, R.T. (1992) Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells, Toxicol. Appl. Pharmacol., 114, 9-15.
22. [22] Bose, R., Verheij, M., Haimoviyz-Friedman, U.K., Scotto, K., Fuks, Z. and Kolesnick, R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals, Cell, 82, 405-414.
23. 1: a molecular mechanism for carcinogenesis associated with Fusarium moniliforme, J. Biol. Chem., 269, 3475-3481.
24. [24] Gelderblom, W.C.A., Snyman, S.D., Abel, S., Lebepe-Mazur, S., Smuts, C.M., Van der Westhuizen, L., Marasas, W.F.O., Victor, T.C., Knasmuller, S. and Huber, W. (1996) Hepatotoxic-and carcinogenicity of the fumonisins in rats: a review regarding mechanistic implications for establishing risk in humans. In: Fumonisins in Food, pp. 279-296. Editors: L.S. Jackson, J.W. De Vries and L.B. Bullerman. Plenum Press, New York.
25. 1. Proc. Am. Assoc. Cancer Res., 132.
26. [26] Sheikh, A., Yusuf, A., Laconi, E., Rao, P.M., Rajalakshmi, S. and Sarma, D.S.R. (1993) Effect of orotic acid in vivo DNA synthesis in hepatocytes of normal rat liver and in hepatic foci/nodules, Carcinogenesis, 14, 907-912.
27. [27] Lindroos, P. and Michalopoulos, G. (1993) Response of phenobarbital-and ciprofibrate-exposed hepatocytes to growth factors in type I collagen gels, Carcinogenesis, 14, 731-735.
28. [28] Tiwawech, D., Hasegawa, R., Kurata, Y., Tatematsu, M., Shibata, M.A., Thamavit, W., Ito, U.K. and Nobuyuki, N. (1991) Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation, Carcinogenesis, 12, 985-990.
29. [29] Goldsworthy, T.L., Hanigan, M.H. and Pitot, H. (1986) Models of hepatocarcinogenesis in the rat: contrasts and comparisons, Crit. Rev. Toxicol., 17, 61-89.
30. [30] Manjeshwar, S., Rao, P.M., Rajalakshmi, S. and Sarma, D.S.R. (1992) Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules, Carcinogenesis, 13, 2287-2291.
31. [31] Eckl, P.M., Meyer, S.A., Whitecomb, W.R. and Jirtle, R.L. (1988) Phenobarbital reduces EGF receptors and the ability of physiological concentration of calcium to suppress hepatocyte proliferation, Carcinogenesis, 9, 479-483.
32. 1 on protein and lipid synthesis in primary rat hepatocytes, Food Chem. Toxicol., 34, 361-369.